Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Gastric Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Contact: Study coordinator (The First Affiliated Hospital FJMU-FAH of Fujian Medical University) · fjydfyjg@163.com · +86 0591 87981029

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer

Gastric Cancer Adenocarcinoma Metastatic

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer

Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)Recruiting

Harbin, China · Baotou, China

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

Gastroesophageal Adenocarcinoma · First Line Therapy · HER2 + Gastric Cancer

Abroad (travel likely)RecruitingPHASE2

Berlin, Germany · Berlin, Germany

INTERACT Stomach-II

Peritoneal Metastases From Gastric Cancer

Abroad (travel likely)RecruitingPHASE2

Amsterdam, Netherlands · Eindhoven, Netherlands